1 story in the last 7 days
The latest triveni bio news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks triveni bio across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
Triveni Bio raised $65 million in Series C funding. The financing round supports the company's development of precision medicines for inflammatory and fibrotic diseases. The funding will advance pipeline programs toward clinical trials.
Summaries by ByteBrief